Novo Nordisk Pre-Tax Income 2010-2025 | NVO

Novo Nordisk pre-tax income for the twelve months ending March 31, 2025 was $19.021B, a 16.83% increase year-over-year.

  • Novo Nordisk annual pre-tax income for 2024 was $18.443B, a 21.34% increase from 2023.
  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.

Novo Nordisk Pre-Tax Income 2010-2025 | NVO

  • Novo Nordisk annual pre-tax income for 2024 was $18.443B, a 21.34% increase from 2023.
  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B